Advertisement

Dystrophic Epidermolysis Bullosa

  • Martin LaimerEmail author
  • Johann W. Bauer
  • Helmut Hintner
Chapter

Abstract

Trauma-induced subepidermal blistering with milia formation, atrophic scarring, and dystrophic nail involvement are cutaneous hallmarks of dystrophic EB (DEB). Severe clinical phenotypes are further complicated by mutilating pseudosyndactyly of hands and feet with contractures and progressive disablement. While in dominant DEB extracutaneous manifestations other than esophageal involvement are rather uncommon, multisystemic disease, involving, e.g., gastrointestinal and genitourinary tract, is frequent in the generalized variants of recessive DEB and causes significant morbidity. The dramatically increased risk for early development of highly aggressive squamous cell carcinomas requires rigorous monitoring, especially in generalized severe RDEB (RDEB-gen sev).

Keywords

Nail Plate Protein Losing Enteropathy Urethral Diverticulum Renal Amyloidosis Atrophic Scarring 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, McGrath JA, Mellerio JE, Murrell DF, Shimizu H, Uitto J, Vahlquist A, Woodley D, Zambruno G. The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol. 2008;58(6):931–50.CrossRefPubMedGoogle Scholar
  2. 2.
    Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol. 2009;61(3):387–402.CrossRefPubMedGoogle Scholar
  3. 3.
    Fine JD. Musculoskeletal deformities. In: Fine JD, Hintner H, editors. Life with epidermolysis bullosa (EB): etiology, diagnosis, multidisciplinary care and therapy. Wien/New York: Springer; 2008. p. 177–84.Google Scholar
  4. 4.
    Moss C, Wong A, Davies P. The Birmingham epidermolysis bullosa severity score: development and validation. Br J Dermatol. 2009;160(5):1057–65.CrossRefPubMedGoogle Scholar
  5. 5.
    Tosti A, Duque-Estrada B, Murrell DF. Alopecia in epidermolysis bullosa. Dermatol Clin. 2010;28(1):165–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Grubauer G, et al. Acquired, surface giant nevus cell nevi in generalized, atrophic, benign epidermolysis bullosa. Hautarzt. 1989;40(8):523–6.PubMedGoogle Scholar
  7. 7.
    Lanschuetzer CM. Epidermolysis bullosa naevi. In: Fine J-D, Hintner H, editors. Life with epidermolysis bullosa. Wien/NewYork: Springer; 2009. p. 107–15.Google Scholar
  8. 8.
    Soltani K, et al. Large acquired nevocytic nevi induced by the Koebner phenomenon. J Cutan Pathol. 1984;11(4):296–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Lanschuetzer CM, et al. Pathogenic mechanisms in epidermolysis bullosa naevi. Acta Derm Venereol. 2003;83(5):332–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Lanschuetzer CM, et al. Epidermolysis bullosa naevi reveal a distinctive dermoscopic pattern. Br J Dermatol. 2005;153(1):97–102.CrossRefPubMedGoogle Scholar
  11. 11.
    Pellicano R, Fabrizi G, Cerimele D. Multiple keratoacanthomas and junctional epidermolysis bullosa. A therapeutic conundrum. Arch Dermatol. 1990;126(3):305–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Swensson O, Christophers E. Generalized atrophic benign epidermolysis bullosa in 2 siblings complicated by multiple squamous cell carcinomas. Arch Dermatol. 1998;134(2):199–203.CrossRefPubMedGoogle Scholar
  13. 13.
    Weber F, et al. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa. Acta Derm Venereol. 2001;81(3):189–92.CrossRefPubMedGoogle Scholar
  14. 14.
    Fine J, et al. Epidermolysis bullosa. Baltimore/London: The Johns Hopkins University Press; 1999.Google Scholar
  15. 15.
    Bauer JW, Schaeppi H, Kaserer C, Hantich B, Hintner H. Large melanocytic nevi in hereditary epidermolysis bullosa. J Am Acad Dermatol. 2001;44(4):577–84.CrossRefPubMedGoogle Scholar
  16. 16.
    Hocker TL, Fox MC, Kozlow JH, Gonzalez JV, Shwayder TA, Lowe L, Chan MP. Malignant melanoma arising in the setting of epidermolysis bullosa simplex: an important distinction from epidermolysis bullosa nevus. JAMA Dermatol. 2013;149(10):1195–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986–2006. J Am Acad Dermatol. 2009;60(2):203–11.CrossRefPubMedGoogle Scholar
  18. 18.
    Reed WB, College Jr J, Francis MJ, Zachariae H, Mohs F, Sher MA, Sneddon IB. Epidermolysis bullosa dystrophica with epidermal neoplasms. Arch Dermatol. 1974;110(6):894–902.CrossRefPubMedGoogle Scholar
  19. 19.
    Dowling J, Yu QC, Fuchs E. Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol. 1996;134(2):559–72.CrossRefPubMedGoogle Scholar
  20. 20.
    van der Neut R, Krimpenfort P, Calafat J, Niessen CM, Sonnenberg A. Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice. Nat Genet. 1996;13(3):366–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Aoki M, Niimi Y, Ishiko A, Kawana S. Pretibial dystrophic epidermolysis bullosa with localized cutaneous amyloidosis: coincidental or secondary amyloidosis? J Dermatol. 2010;37(3):259–63.CrossRefPubMedGoogle Scholar
  22. 22.
    Fan YM, Yang YP, Li SF. Medical genetics: sporadic dystrophic epidermolysis bullosa with albopapuloid and prurigo- and folliculitis-like lesions. Int J Dermatol. 2009;48(8):855–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Almaani N, Liu L, Perez A, Robson A, Mellerio JE, McGrath JA. Epidermolysis bullosa pruriginosa in association with lichen planopilaris. Clin Exp Dermatol. 2009;34(8):e825–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Nomura K, Umeki K, Sawamura D, Hashimoto I. Dominant dystrophic epidermolysis bullosa albopapuloidea Pasini—ultrastructural observations of albopapuloid lesions and a type VII collagen DNA polymorphism study of a family. Acta Derm Venereol. 1997;77(4):277–80.PubMedGoogle Scholar
  25. 25.
    McKee PH, Calonje E, Granter SR. Pathology of the skin, vol. 1. Philadelphia: Elsevier Mosby; 2005. p. 89.Google Scholar
  26. 26.
    Bruckner-Tuderman L, Schnyder UW, Baran R. Nail changes in epidermolysis bullosa: clinical and pathogenetic considerations. Br J Dermatol. 1995;132(3):339–44.CrossRefPubMedGoogle Scholar
  27. 27.
    Tosti A, de Farias DC, Murrell DF. Nail involvement in epidermolysis bullosa. Dermatol Clin. 2010;28(1):153–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Dharma B, Moss C, McGrath JA, Mellerio JE, Ilchyshyn A. Dominant dystrophic epidermolysis bullosa presenting as familial nail dystrophy. Clin Exp Dermatol. 2001;26(1):93–6.PubMedGoogle Scholar
  29. 29.
    Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61(3):367–84.CrossRefPubMedGoogle Scholar
  30. 30.
    Figueira EC, Murrell DF, Coroneo MT. Ophthalmic involvement in inherited epidermolysis bullosa. Dermatol Clin. 2010;28(1):143–52.CrossRefPubMedGoogle Scholar
  31. 31.
    Tong L, Hodgkins PR, Denyer J, Brosnahan D, Harper J, Russell-Eggitt I, Taylor DS, Atherton D. The eye in epidermolysis bullosa. Br J Ophthalmol. 1999;83(3):323–6.CrossRefPubMedCentralPubMedGoogle Scholar
  32. 32.
    Hore I, Bajaj Y, Denyer J, Martinez AE, Mellerio JE, Bibas T, Albert D. The management of general and disease specific ENT problems in children with epidermolysis bullosa—a retrospective case note review. Int J Pediatr Otorhinolaryngol. 2007;71(3):385–91.CrossRefPubMedGoogle Scholar
  33. 33.
    Wright JT. Oral manifestations in the epidermolysis bullosa spectrum. Dermatol Clin. 2010;28(1):159–64.CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    Fine JD, Johnson LB, Weiner M, Suchindran C. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. J Pediatr Gastroenterol Nutr. 2008;46(2):147–58.CrossRefPubMedGoogle Scholar
  35. 35.
    Almaani N, Mellerio JE. Genitourinary tract involvement in epidermolysis bullosa. Dermatol Clin. 2010;28(2):343–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Fine JD. Other internal complications. In: Fine JD, Hintner H, editors. Life with epidermolysis bullosa (EB): etiology, diagnosis, multidisciplinary care and therapy. Wien/New York: Springer; 2008. p. 185–96.Google Scholar
  37. 37.
    Hanafusa T, Tamai K, Umegaki N, Yamaguchi Y, Fukuda S, Nishikawa Y, Yaegashi N, Okuyama R, McGrath JA, Katayama I. The course of pregnancy and childbirth in three mothers with recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol. 2012;37:10–4.CrossRefPubMedGoogle Scholar
  38. 38.
    Choi SD, Kho YC, Rhodes LM, Davis GK, Chapman MG, Murrell DF. Outcomes of 11 pregnancies in three patients with recessive forms of epidermolysis bullosa. Br J Dermatol. 2011;165(3):700–1.CrossRefPubMedGoogle Scholar
  39. 39.
    Tyring SK, Chopra V, Johnson L, Fine JD. Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa. Arch Dermatol. 1989;125(6):797–800.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Martin Laimer
    • 1
    Email author
  • Johann W. Bauer
    • 1
  • Helmut Hintner
    • 1
  1. 1.Department of DermatologyGeneral Hospital Salzburg, Paracelsus Medical UniversitySalzburgAustria

Personalised recommendations